Galor Anat

Galor Anat, Henderson Bonnie, Ifantides Cristos, Stefater James A, Stryjewski Tomasz P

A single scleral cooling device application in rabbits showed no adverse effects for 8 weeks, suggesting it's a safe, novel approach for chronic ocular surface pain.

Kahook Malik Y, Rapuano Christopher J, Messmer Elisabeth M, Radcliffe Nathan M, Galor Anat, Baudouin Christophe

Preservatives in glaucoma drops, especially BAK, cause ocular surface disease. Reducing/eliminating BAK via preservative-free options or non-pharmacological treatments improves patient quality of life and surgical outcomes.

Mandell Jordan T, de Rivero Vaccari Juan Pablo, Sabater Alfonso L, Galor Anat

Inflammasomes are key in many ocular diseases, including glaucoma. Targeting this pathway offers promising new therapeutic strategies to reduce inflammation and disease progression.

Camp Andrew S, Long Christopher P, Galor Anat, Yamane Maya, Proudfoot James A, Weinreb Robert N

This study found dry eye severity increases visual field tracking failures (TFF), especially in the left eye. This suggests TFF thresholds may need adjustment for dry eye patients, improving glaucoma monitoring.

Yusuf Ramsey, Galor Anat, Goldhagen Brian

Tovar Arianna, Gomez Angela, Serrano Andres, Blanco Maricarmen Perez, Galor Anat, Swaminathan Swarup S et al.

This study found elevated tear caspase-1 in ocular surface damage, correlating with clinical signs, suggesting its potential as a diagnostic biomarker and therapeutic target.

Naranjo Andrea, Pirakitikulr Nathan, Pelaez Daniel, Sabater Alfonso L, Monsalve Pedro, Amescua Guillermo et al.

This study linked retrocorneal membranes causing DSAEK failure, especially with glaucoma drainage devices, to myofibroblastic differentiation, suggesting endothelial origin and potential for targeted therapies.

Wang Ye Elaine, Galor Anat, Junk Anna K

A glaucoma patient developed corneal edema post-CyPass implantation, likely due to device proximity and underlying dystrophy. Revision improved edema, highlighting careful microstent placement and corneal health assessment.

Tzu Jonathan H, Shah Christopher T, Galor Anat, Junk Anna K, Sastry Ananth, Wellik Sarah R

Combined cataract and glaucoma surgery achieved favorable refractive outcomes (74%), but less predictably than cataract surgery alone, inducing more astigmatism. Older patients had worse outcomes.

Shah Aparna A, Modi Yasha, Thomas Benjamin, Wellik Sarah R, Galor Anat

Brimonidine eye drops can cause allergic reactions mimicking vernal keratoconjunctivitis, highlighting the need to differentiate drug allergy from underlying ocular surface disease for effective treatment.

Anwar Zane, Wellik Sarah R, Galor Anat

Glaucoma eye drops, especially those with BAK, worsen ocular surface disease. Newer preservative-free or BAK-free options show clinical benefit, highlighting the need to consider these alternatives for patient comfort.

Leder Henry A, Jabs Douglas A, Galor Anat, Dunn James P, Thorne Jennifer E

Periocular triamcinolone injections resolved uveitic cystoid macular edema in over half of patients, improving vision, but recurrence was common, highlighting its role as an effective but temporary treatment.

Galor Anat, Margolis Ron, Brasil Oswaldo M F, Perez Victor L, Kaiser Peter K, Sears Jonathan E et al.

This study found intravitreal triamcinolone causes more IOP elevation and cataract progression in uveitis patients, highlighting the need for close monitoring and risk counseling in this group.